Glucagon-like peptide-1 preserves coronary microvascular endothelial function after cardiac arrest and resuscitation: potential antioxidant effects
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Glucagon-like peptide-1 preserves coronary microvascular endothelial function after cardiac arrest and resuscitation: potential antioxidant effects
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
Volume 304, Issue 4, Pages H538-H546
Publisher
American Physiological Society
Online
2012-12-16
DOI
10.1152/ajpheart.00282.2012
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sudden Cardiac Death Caused by Coronary Heart Disease
- (2012) Robert J. Myerburg et al. CIRCULATION
- Antiapoptotic effects of GLP-1 in murine HL-1 cardiomyocytes
- (2011) Susana Ravassa et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- A Pilot Study to Assess Whether Glucagon-Like Peptide-1 Protects the Heart From Ischemic Dysfunction and Attenuates Stunning After Coronary Balloon Occlusion in Humans
- (2011) Philip A. Read et al. Circulation-Cardiovascular Interventions
- The Possible Protective Role of Glucagon-Like Peptide 1 on Endothelium During the Meal and Evidence for an "Endothelial Resistance" to Glucagon-Like Peptide 1 in Diabetes
- (2011) A. Ceriello et al. DIABETES CARE
- Cardioprotection against ischaemia induced by dobutamine stress using glucagon-like peptide-1 in patients with coronary artery disease
- (2011) Philip A Read et al. HEART
- Glucagon-like Peptide-1 (GLP-1), Immediately Prior to Reperfusion, Decreases Neutrophil Activation and Reduces Myocardial Infarct Size in Rodents
- (2011) B. B. Dokken et al. HORMONE AND METABOLIC RESEARCH
- Exendin-4, a Glucagon-Like Peptide-1 Receptor Agonist, Provides Neuroprotection in Mice Transient Focal Cerebral Ischemia
- (2011) Shinichiro Teramoto et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Exenatide Exerts a Potent Antiinflammatory Effect
- (2011) Ajay Chaudhuri et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Dark chocolate inhibits platelet isoprostanes via NOX2 down-regulation in smokers
- (2011) R. CARNEVALE et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Propofol mitigates systemic oxidative injury during experimental cardiopulmonary cerebral resuscitation
- (2011) Samar Basu et al. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
- GLP-1-derived nonapeptide GLP-1(28–36)amide targets to mitochondria and suppresses glucose production and oxidative stress in isolated mouse hepatocytes
- (2011) Eva Tomas et al. REGULATORY PEPTIDES
- Cool flow—The microcirculation in cardiac arrest patients treated with therapeutic hypothermia
- (2011) Michael Fries et al. RESUSCITATION
- Sublingual and muscular microcirculatory alterations after cardiac arrest: A pilot study
- (2011) Katia Donadello et al. RESUSCITATION
- Glucagon-Like Peptide 1 Prevents Reactive Oxygen Species–Induced Endothelial Cell Senescence Through the Activation of Protein Kinase A
- (2010) Hisko Oeseburg et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Inherited Human gp91 phox Deficiency Is Associated With Impaired Isoprostane Formation and Platelet Dysfunction
- (2010) Pasquale Pignatelli et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Glucagon-like peptide-1 counteracts the detrimental effects of Advanced Glycation End-Products in the pancreatic beta cell line HIT-T 15
- (2010) A. Puddu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Neonatal Exendin-4 Leads to Protection from Reperfusion Injury and Reduced Rates of Oxidative Phosphorylation in the Adult Rat Heart
- (2010) Suzanne B. Brown et al. CARDIOVASCULAR DRUGS AND THERAPY
- Role of NADPH Oxidase in Endothelial Ischemia/Reperfusion Injury in Humans
- (2010) Stavros P. Loukogeorgakis et al. CIRCULATION
- Incretin Concepts
- (2010) Z. T. Bloomgarden DIABETES CARE
- Risk of Cardiovascular Disease Events in Patients With Type 2 Diabetes Prescribed the Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Exenatide Twice Daily or Other Glucose-Lowering Therapies: A retrospective analysis of the LifeLink database
- (2010) J. H. Best et al. DIABETES CARE
- Glucagon-like peptide-1 (GLP-1) attenuates post-resuscitation myocardial microcirculatory dysfunction
- (2010) Betsy B. Dokken et al. RESUSCITATION
- Post-resuscitation myocardial microcirculatory dysfunction is ameliorated with eptifibatide
- (2010) Karl B. Kern et al. RESUSCITATION
- 122 Substance P Induce Nitric Oxide Production in Human Microvascular Endothelial Cells
- (2010) P Muangman et al. WOUND REPAIR AND REGENERATION
- Treatment of spontaneously hypertensive rats with rosiglitazone ameliorates cardiovascular pathophysiology via antioxidant mechanisms in the vasculature
- (2009) Maria A. Potenza et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Glucagon-like peptide-1 (GLP-1) inhibits advanced glycation end product (AGE)-induced up-regulation of VCAM-1 mRNA levels in endothelial cells by suppressing AGE receptor (RAGE) expression
- (2009) Yuji Ishibashi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Porcine Marginal Mass Islet Autografts Resist Metabolic Failure Over Time and Are Enhanced by Early Treatment with Liraglutide
- (2009) Juliet A. Emamaullee et al. ENDOCRINOLOGY
- Hypothermia attenuates ischemia/reperfusion-induced endothelial cell apoptosis via alterations in apoptotic pathways and JNK signaling
- (2009) Dan Yang et al. FEBS LETTERS
- A long-acting glucagon-like peptide-1 analogue attenuates induction of plasminogen activator inhibitor type-1 and vascular adhesion molecules
- (2009) Hongbin Liu et al. JOURNAL OF ENDOCRINOLOGY
- Exenatide Reduces Infarct Size and Improves Cardiac Function in a Porcine Model of Ischemia and Reperfusion Injury
- (2009) Leo Timmers et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Glucagon-like peptide-1 protects mesenteric endothelium from injury during inflammation
- (2009) Kristopher C. Dozier et al. PEPTIDES
- Changes in Myocardial Perfusion Correlate With Deterioration of Left Ventricular Systolic Function in Chronic Chagas' Cardiomyopathy
- (2009) Flávio C. Hiss et al. JACC-Cardiovascular Imaging
- Cardioprotective and Vasodilatory Actions of Glucagon-Like Peptide 1 Receptor Are Mediated Through Both Glucagon-Like Peptide 1 Receptor–Dependent and –Independent Pathways
- (2008) Kiwon Ban et al. CIRCULATION
- Chronic Glucagon-Like Peptide-1 Infusion Sustains Left Ventricular Systolic Function and Prolongs Survival in the Spontaneously Hypertensive, Heart Failure–Prone Rat
- (2008) Indu Poornima et al. Circulation-Heart Failure
- Myocardial microcirculatory dysfunction after prolonged ventricular fibrillation and resuscitation
- (2008) Karl B. Kern et al. CRITICAL CARE MEDICINE
- Brain Glucagon-Like Peptide-1 Regulates Arterial Blood Flow, Heart Rate, and Insulin Sensitivity
- (2008) C. Cabou et al. DIABETES
- The Potential Beneficial Role of Glucagon-like Peptide-1 in Endothelial Dysfunction and Heart Failure Associated with Insulin Resistance
- (2008) T. Nyström HORMONE AND METABOLIC RESEARCH
- Myocardial cytokine IL-8 and nitric oxide synthase activity during and after resuscitation: Preliminary observations in regards to post-resuscitation myocardial dysfunction
- (2008) Karl B. Kern et al. RESUSCITATION
- Post-cardiac arrest syndrome: Epidemiology, pathophysiology, treatment, and prognostication
- (2008) Jerry P. Nolan et al. RESUSCITATION
- The Interaction Between Coronary Endothelial Dysfunction, Local Oxidative Stress, and Endogenous Nitric Oxide in Humans
- (2007) Shahar Lavi et al. HYPERTENSION
- Protective effects of GLP-1 analogues exendin-4 and GLP-1(9–36) amide against ischemia–reperfusion injury in rat heart
- (2007) David P. Sonne et al. REGULATORY PEPTIDES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More